颖泰生物
(920819)
| 流通市值：51.20亿 | | | 总市值：51.97亿 |
| 流通股本：12.08亿 | | | 总股本：12.26亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,018,052,897.72 | 960,486,549.6 | 1,201,314,356.87 | 1,115,897,036.2 |
| 交易性金融资产 | 725,584.92 | 1,178,100.54 | 977,768.91 | - |
| 应收票据及应收账款 | 1,494,237,803.81 | 1,353,018,679.05 | 1,363,029,983.69 | 1,427,417,547.3 |
| 应收账款 | 1,494,237,803.81 | 1,353,018,679.05 | 1,363,029,983.69 | 1,427,417,547.3 |
| 应收款项融资 | 118,289,036.62 | 149,003,533.91 | 111,920,081.67 | 111,528,592.29 |
| 预付款项 | 61,231,201.42 | 45,795,232.45 | 69,951,444.57 | 56,496,381.15 |
| 其他应收款合计 | 72,254,555.82 | 63,803,460.22 | 52,780,940.23 | 50,842,899.18 |
| 其中:应收利息 | 6,266,286.11 | 6,523,991.66 | 7,146,255.56 | 8,584,963.89 |
| 存货 | 1,335,150,954.94 | 1,463,473,388.6 | 1,553,012,289.72 | 1,550,020,658.03 |
| 合同资产 | 15,206,998.72 | 15,068,751.17 | 15,542,037.52 | 14,617,204.76 |
| 其他流动资产 | 239,007,351.22 | 240,689,004.04 | 186,665,838.23 | 222,996,839.22 |
| 流动资产合计 | 4,354,156,385.19 | 4,292,516,699.58 | 4,555,194,741.41 | 4,549,817,158.13 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,700,636,156.35 | 1,754,495,860.89 | 1,730,342,867.64 | 1,714,790,751 |
| 投资性房地产 | 108,588,898.92 | 109,536,670.64 | 110,484,442.28 | 111,432,214 |
| 固定资产 | 3,042,171,583.71 | 3,144,212,629.64 | 3,237,627,257.05 | 3,358,327,328.04 |
| 在建工程 | 905,206,815.96 | 891,456,616.88 | 849,790,830.08 | 785,637,868.13 |
| 使用权资产 | 32,765,041.02 | 33,231,890.33 | 37,000,916.47 | 37,484,433.07 |
| 无形资产 | 681,656,482.72 | 691,426,073.68 | 702,089,767.54 | 711,931,308.34 |
| 商誉 | 374,366,777.39 | 374,366,777.39 | 374,366,777.39 | 374,366,777.39 |
| 长期待摊费用 | 20,480,412.42 | 21,359,494.06 | 28,373,710.96 | 24,530,039.83 |
| 递延所得税资产 | 171,070,222.32 | 161,786,992.44 | 154,172,381.02 | 150,975,903.6 |
| 其他非流动资产 | 104,544,478.87 | 80,635,617.37 | 78,375,400.12 | 86,803,863.18 |
| 非流动资产合计 | 7,141,486,869.68 | 7,262,508,623.32 | 7,302,624,350.55 | 7,356,280,486.58 |
| 资产总计 | 11,495,643,254.87 | 11,555,025,322.9 | 11,857,819,091.96 | 11,906,097,644.71 |
| 流动负债: | | | | |
| 短期借款 | 2,566,982,443.68 | 2,427,103,258.64 | 2,741,509,561.77 | 2,612,915,817.81 |
| 应付票据及应付账款 | 1,306,166,670.33 | 1,525,036,684.47 | 1,602,092,799.31 | 1,637,225,069.86 |
| 其中：应付票据 | 643,307,455.34 | 583,388,059.29 | 872,097,405.89 | 816,561,426.05 |
| 应付账款 | 662,859,214.99 | 941,648,625.18 | 729,995,393.42 | 820,663,643.81 |
| 预收款项 | 974,558.81 | 358,757.04 | - | 661,412.92 |
| 合同负债 | 90,299,045.08 | 45,770,303.65 | 52,676,357.5 | 124,024,872.33 |
| 应付职工薪酬 | 74,572,923.24 | 78,775,538.59 | 76,732,105.9 | 127,518,988.69 |
| 应交税费 | 27,519,492.06 | 30,981,930.18 | 25,171,187.88 | 46,835,279.24 |
| 其他应付款合计 | 119,866,649.09 | 128,061,335.26 | 129,666,580.54 | 234,143,395.29 |
| 一年内到期的非流动负债 | 812,942,469.55 | 990,886,595.55 | 1,120,648,680.17 | 1,056,744,714 |
| 其他流动负债 | 6,828,948.48 | 2,723,078.05 | 1,992,100.33 | 6,954,058.29 |
| 流动负债合计 | 5,006,153,200.32 | 5,229,697,481.43 | 5,750,489,373.4 | 5,847,023,608.43 |
| 非流动负债: | | | | |
| 长期借款 | 1,259,520,487.09 | 1,072,636,161.41 | 883,846,535.52 | 849,146,118.05 |
| 租赁负债 | 16,958,107.1 | 17,427,142.91 | 20,181,993.71 | 20,750,418.22 |
| 长期应付款 | 4,692,391.75 | 5,384,729.75 | 5,408,219.75 | 5,388,259.75 |
| 递延收益 | 114,600,478.35 | 101,280,636.51 | 99,747,251.01 | 99,153,947.52 |
| 递延所得税负债 | 46,582,292.35 | 46,648,095.64 | 48,368,380.56 | 48,709,444.34 |
| 非流动负债合计 | 1,442,353,756.64 | 1,243,376,766.22 | 1,057,552,380.55 | 1,023,148,187.88 |
| 负债合计 | 6,448,506,956.96 | 6,473,074,247.65 | 6,808,041,753.95 | 6,870,171,796.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 |
| 资本公积 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 |
| 其他综合收益 | -73,696,148.34 | -63,332,881.93 | -86,944,565.71 | -98,624,732.47 |
| 专项储备 | 9,672,407.87 | 9,586,516.93 | 9,519,555.01 | 8,111,777.04 |
| 盈余公积 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 |
| 未分配利润 | 667,287,935.3 | 692,205,384.78 | 679,262,914.17 | 676,914,509.76 |
| 归属于母公司股东权益合计 | 5,061,384,997.05 | 5,096,579,822 | 5,059,958,705.69 | 5,044,522,356.55 |
| 少数股东权益 | -14,248,699.14 | -14,628,746.75 | -10,181,367.68 | -8,596,508.15 |
| 股东权益合计 | 5,047,136,297.91 | 5,081,951,075.25 | 5,049,777,338.01 | 5,035,925,848.4 |
| 负债和股东权益合计 | 11,495,643,254.87 | 11,555,025,322.9 | 11,857,819,091.96 | 11,906,097,644.71 |
| 公告日期 | 2025-10-24 | 2025-08-15 | 2025-04-18 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |